Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal Rebleeding
Open Access
- 20 June 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (25), 1624-1629
- https://doi.org/10.1056/nejm199606203342502
Abstract
Patients who have bleeding from esophageal varices are at high risk for rebleeding and death. We compared the efficacy and safety of endoscopic sclerotherapy with the efficacy and safety of nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.Keywords
This publication has 31 references indexed in Scilit:
- Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failureJournal of Hepatology, 1994
- New approaches in the pharmacologic treatment of portal hypertensionJournal of Hepatology, 1993
- Propranolol versus sclerotherapy in preventing variceal rebleeding: A randomized controlled trialGastroenterology, 1993
- Definitions, methodology and therapeutic strategies in portal hypertension: A consensus development workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990Journal of Hepatology, 1992
- Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapyJournal of Hepatology, 1991
- Efficacy of Ethanolamine and Polidocanol in the Eradication of Esophageal Varices. A Prospective Randomized TrialEndoscopy, 1989
- Morbidity and Mortality of Portal HypertensionDrugs, 1989
- Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding: A prospective, randomized controlled trialJournal of Hepatology, 1988
- Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective, randomized comparison of propranolol and sclerotherapyHepatology, 1987
- Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertensionAmerican Heart Journal, 1984